Logo
x

Search

Subscribe Now

Teva

Teva and Samsung Bioepis Launch Epysqli (Biosimilar, Soliris) in the US

Teva and Samsung Bioepis Launch Epysqli (Biosimilar, Soliris) in the US

  • April 8, 2025
Teva Partners with Klinge Biopharma & Formycon to Commercialize FYB203 (Biosimilar: Aflibercept) in EU & Israel

Teva Partners with Klinge Biopharma & Formycon to Commercialize FYB203 (Biosimilar: Aflibercept) in EU & Israel

  • January 14, 2025
Teva and mAbxience Join Forces on Second Biosimilar Candidate in Oncology

Teva and mAbxience Join Forces on Second Biosimilar Candidate in Oncology

  • October 4, 2024
Insights+ Key Biosimilars Events of May 2024

Insights+ Key Biosimilars Events of May 2024

  • June 4, 2024
Teva and Alvotech Launches Simlandi (Biosimilar, Humira) Injection Across US to Treat Multiple Indications

Teva and Alvotech Launches Simlandi (Biosimilar, Humira) Injection Across US to Treat Multiple Indications

  • May 20, 2024
Teva and Alvotech’s Selarsdi (Biosimilar, Stelara) Receives the US FDA’s Approval

Teva and Alvotech’s Selarsdi (Biosimilar, Stelara) Receives the US FDA’s Approval

  • April 17, 2024
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2025 PharmaShots - All Rights Reserved.